Genmab A/S annual revenue
2022
2023
2024
2025
Genmab A/S Revenue Growth & History (GMAB)
Genmab A/S reported $3.72B in revenue for fiscal 2025, an increase of 19.19% from the previous fiscal year.
View full Genmab A/S company overviewGenmab A/S annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3.72B | $599.0M | +19.19% |
| 2024 | 2024-12-31 | $3.12B | $731.0M | +30.59% |
| 2023 | 2023-12-31 | $2.39B | $302.3M | +14.48% |
| 2022 | 2022-12-31 | $2.09B | — | — |
Genmab A/S quarterly revenue
Q2.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.16B | $230.0M | +24.86% |
| Q1 2026 | 2026-03-31 | $896.0M | — | — |
| Q4 2025 | 2025-12-31 | $1.06B | — | — |
| Q3 2025 | 2025-09-30 | $1.02B | — | — |
| Q2 2025 | 2025-06-30 | $925.0M | $146.0M | +18.74% |
| Q2 2024 | 2024-06-30 | $779.0M | — | — |
Genmab A/S revenue growth trends
Genmab A/S's latest reported quarter, Q2 2026, generated $1.16B in revenue, an increase of 24.86% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Genmab A/S source filings ↗